To this end, we first compared ERBB1 mRNA expression levels in the MLC from DLBCL patients with different histologic subtypes who had died within 2.5 years vs. those who remained alive at 2.5 years. The gene discussed is EGFR; the disease is diffuse large B-cell lymphoma.